FDA Halts New Clinical Trials Exporting Americans’ Cells to Hostile Foreign Labs for Genetic Engineering
The FDA has announced a review of new clinical trials that “involve sending American citizens’ living cells to China and other hostile countries for genetic engineering and subsequent infusion back into U.S. patients – sometimes without their knowledge or consent.” The press release further explains that there is “mounting evidence” that participants did not receive…Continue reading FDA Halts New Clinical Trials Exporting Americans’ Cells to Hostile Foreign Labs for Genetic Engineering